Atherogenic risk assessment of naive HIV-infected patients attending Infectious Diseases Service of Kinshasa University Teaching Hospital, Democratic Republic of the Congo (DRC)
Open Access
- 13 October 2020
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 3 (1), 040-048
- https://doi.org/10.29328/journal.ijcmbt.1001015
Abstract
Background and aim: Metabolic abnormalities are common in HIV/AIDS. Increasingly, lipid ratios are used as screening tools for dyslipidaemia in these medical conditions. The aim of this study was to assess the ability of 4 lipid ratios to predict cardiovascular risks. Methods: This is a cross-sectional and analytical study included 105 HIV+ patients followed in Kinshasa University Teaching Hospital (KUTH). Four indices [Atherogenic Index of Plasma (AIP), Castelli Risk Index (CRI) I and II, Atherogenic coefficient (AC)] were compared. Statistical analyzis consisted of measuring frequencies and means, Student’s t-tests, ANOVA and Ficher’s exact test, and the calculation of the Kappa value. Results: Lipid ratios predicted respectively the risk in 62% (AIP), 28.6% (CRI-I) and 23.8% (CRI-II). CRI-I and II were elevated, especially in women. The AIP appeared to be a better predictor than CRI-I and II to assess dyslipidaemia in general and the high-risk frequency. The cholesterol detected risk in 66.7% (Low HDL-C), 50% (High LDL-C), 38.9% (High TC and/or TG). The atherogenic risk was higher with age, advanced WHO stage, HIV-TB, HBV-HCV co-infections, smoking and alcohol intake. Haemoglobin (Hb) and CD4 counts were low when the risk was high. Age ≥ 50 years, stage 4 (WHO), CD4s+ ≤ 200 cells/µL were independent factors associated with atherogenic risk. Conclusion: Lipid ratios can be used as reliable tools for assessing cardiovascular risk of naïve HIV-infected patients who received HAART.Keywords
This publication has 25 references indexed in Scilit:
- HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD CollaborativeClinical Infectious Diseases, 2016
- Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsOpen Forum Infectious Diseases, 2016
- Risk factors and assessment for cardiovascular disease among HIV-positive patients attending a Nigerian tertiary hospitalPan African Medical Journal, 2016
- Cardiovascular risk prediction in HIV‐infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE‐NL) and Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) risk prediction modelsHIV Medicine, 2015
- A Study on Atherogenic Indices of Pregnancy Induced Hypertension Patients as Compared to Normal Pregnant WomenJournal of Clinical and Diagnostic Research, 2015
- Cardiovascular disease in HIV patients: from bench to bedside and backwardsOpen Heart, 2015
- HDL in Infectious Diseases and SepsisPublished by Springer Science and Business Media LLC ,2014
- The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian populationBMC Public Health, 2014
- Atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast NigeriaIndian Journal of Endocrinology and Metabolism, 2014
- The end of AIDS: HIV infection as a chronic diseaseThe Lancet, 2013